Literature DB >> 21919888

Thr90 phosphorylation of Hsp90α by protein kinase A regulates its chaperone machinery.

Xiaofeng Wang1, Xin-an Lu, Xiaomin Song, Wei Zhuo, Lin Jia, Yushan Jiang, Yongzhang Luo.   

Abstract

Hsp90 (heat-shock protein 90) is one of the most important molecular chaperones in eukaryotes. Hsp90 facilitates the maturation, activation or degradation of its client proteins. It is now well accepted that both ATP binding and co-chaperone association are involved in regulating the Hsp90 chaperone machinery. However, other factors such as post-translational modifications are becoming increasingly recognized as being involved in this process. Recent studies have reported that phosphorylation of Hsp90 plays an unanticipated role in this process. In the present study, we systematically investigated the impact of phosphorylation of a single residue (Thr90) of Hsp90α (pThr90-Hsp90α) on its chaperone machinery. We demonstrate that protein kinase A specifically phosphorylates Hsp90α at Thr90, and that the pThr9090-Hsp90α level is significantly elevated in proliferating cells. Thr90 phosphorylation affects the binding affinity of Hsp90α to ATP. Subsequent examination of the interactions of Hsp90α with co-chaperones reveals that Thr90 phosphorylation specifically regulates the association of a subset of co-chaperones with Hsp90α. The Hsp90α T90E phosphor-mimic mutant exhibits increased association with Aha1 (activator of Hsp90 ATPase homologue 1), p23, PP5 (protein phosphatase 5) and CHIP (C-terminus of Hsp70-interacting protein), and decreased binding affinity with Hsp70, Cdc37 (cell division cycle 37) and Hop [Hsc70 (heat-shock cognate protein 70)/Hsp90-organizing protein], whereas its interaction with FKBP52 (FK506-binding protein 4) is only moderately affected. Moreover, we find that the ability of the T90E mutant to form complexes with its clients, such as Src, Akt or PKCγ (protein kinase Cγ), is dramatically impaired, suggesting that phosphorylation affects its chaperoning activity. Taken together, the results of the present study demonstrate that Thr90 phosphorylation is actively engaged in the regulation of the Hsp90α chaperone machinery and should be a generic determinant for the cycling of Hsp90α chaperone function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21919888     DOI: 10.1042/BJ20110855

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  6 in total

Review 1.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

2.  Progesterone requires heat shock protein 90 (HSP90) in human sperm to regulate motility and acrosome reaction.

Authors:  Vrushali Sagare-Patil; Rashmi Bhilawadikar; Mosami Galvankar; Kusum Zaveri; Indira Hinduja; Deepak Modi
Journal:  J Assist Reprod Genet       Date:  2017-02-24       Impact factor: 3.412

3.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

Review 4.  Tumor-intrinsic and tumor-extrinsic factors impacting hsp90- targeted therapy.

Authors:  S V Alarcon; M Mollapour; M-J Lee; S Tsutsumi; S Lee; Y S Kim; T Prince; A B Apolo; G Giaccone; W Xu; L M Neckers; J B Trepel
Journal:  Curr Mol Med       Date:  2012-11-01       Impact factor: 2.222

5.  The regulatory mechanism of a client kinase controlling its own release from Hsp90 chaperone machinery through phosphorylation.

Authors:  Xin-an Lu; Xiaofeng Wang; Wei Zhuo; Lin Jia; Yushan Jiang; Yan Fu; Yongzhang Luo
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

6.  A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic.

Authors:  Wei Liu; Jie Li; Ping Zhang; Qiaoyun Hou; Shi Feng; Lisheng Liu; Dawei Cui; Hubing Shi; Yan Fu; Yongzhang Luo
Journal:  Cancer Sci       Date:  2019-08-09       Impact factor: 6.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.